BRIEF-Threshold Pharma says first patient dosed in clinical trial of evofosfamide, ipilimumab
June 13, 2017 at 08:16 AM EDT
* Threshold Pharmaceuticals announces first patient dosed in immunotherapy clinical trial of evofosfamide and ipilimumab